Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.

Maria L Gonzalez SuarezCharat ThongprayoonMichael A MaoNapat LeeaphornTarun BathiniWisit Cheungpasitporn

Published in: Journal of clinical medicine (2019)

This study summarizes the outcomes observed with use of eculizumab for prevention and treatment of aHUS recurrence in kidney transplantation. Our results suggest a possible role for anti-C5 antibody therapy in the prevention and management of recurrent aHUS.

Keyphrases

kidney transplantation
type diabetes
metabolic syndrome
skeletal muscle
mesenchymal stem cells
combination therapy
free survival
replacement therapy